NEXT Oncology - Hospital Quironsalud Barcelona - PPDS

Barcelona 08023

1 studies enrolling now · 1 studies all time

What they study most

HR+/HER2-negative Breast Cancer

Studies at this site

• A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer — Recruiting now